Trials / Unknown
UnknownNCT05104970
Comparative Pharmacokinetics of Two Different Oral Delivery Systems of Cholecalciferol
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Scotmann Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to adapt the gold standard of research and to explore the comparative bioavailability and clinical efficacy of the two most commonly used forms of Cholecalciferol i.e. ampoules and softgel capsules.
Detailed description
Deficiency of Vitamin D is highly prevalent in all sectors and regions of Pakistan. Its effects encompass multiple pluripotent physiological impacts on human body, including its classical action on bone health and immune modulation. Health care workers are routinely prescribing supplementations to correct the deficiencies. Different forms of Cholecalciferol are available in the market. It ranges from absorba liquids, drops, tablets, softgels to injectable and oral ampoules. Different delivery systems offer different advantages, challenges and efficacies specific to their specific pharmacokinetics. The aim of this study is to adapt the gold standard of research and to explore the comparative bioavailability and clinical efficacy of the two most commonly used forms of Cholecalciferol i.e. ampoules and softgel capsules.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SunnyD insta ampoule | Cholecalciferol 200000 IU insta ampoule |
| DIETARY_SUPPLEMENT | SunnyD STAT softgel capsule | Cholecalciferol 200000 IU softgel capsule |
| DRUG | Placebo SunnyD insta ampoule | Olive oil |
| DIETARY_SUPPLEMENT | Placebo SunnyD STAT softgel capsule | Olive oil |
Timeline
- Start date
- 2022-08-09
- Primary completion
- 2023-01-09
- Completion
- 2023-02-10
- First posted
- 2021-11-03
- Last updated
- 2022-05-26
Source: ClinicalTrials.gov record NCT05104970. Inclusion in this directory is not an endorsement.